The Autonomic Nervous System (ANS) is a part of the central nervous system responsible for influencing and controlling different organs, structures, and glands of the body. It is made up of two subdivisions: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PSNS). The sympathetic division is responsible for activating the body's "fight or flight" response, which helps the body work more efficiently in times of stress, while the parasympathetic division is primarily responsible for calming the body and restoring a homeostatic balance. The ANS is part of a large network of neurons and nerve fibers, which are interconnected to nerve cells in the brain and spinal cord. This network works together to control different organs and regulate bodily processes such as digestion, blood pressure, respiration, temperature, and heart rate. The ANS is capable of operating without conscious thought, such as when the body automatically regulates its breathing while sleeping. It is also responsible for triggering and controlling the body's involuntary responses to emotions or physical stimulus. The ANS is controlled by neurotransmitters which act as chemical messengers that travel between neurons and are responsible for carrying impulses through the nervous system. The neurotransmitters that influence the ANS are acetylcholine, adrenaline, noradrenaline, and serotonin. When these neurotransmitters are released by the ANS, they cause changes in the body such as an increased heart rate, perspiration, and respiration. In summary, the Autonomic Nervous System is an essential part of the body responsible for influencing and controlling the organs and glands, thereby maintaining homeostasis. Its subdivisions, the SNS and PSNS, work together to trigger involuntary responses as well as calming the body in response to physical and emotional stimulus. It is driven by four primary neurotransmitters which help regulate the body’s functions and preserve a consistent physiological environment.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States